{"id":"https://openalex.org/W1990362020","doi":"https://doi.org/10.2174/1568007024606258","title":"N-Methyl-D-Aspartate Receptor-Coupled GlycineB Receptors in the Pathogenesis and Treatment of Schizophrenia: A Critical Review","display_name":"N-Methyl-D-Aspartate Receptor-Coupled GlycineB Receptors in the Pathogenesis and Treatment of Schizophrenia: A Critical Review","alternate_titles":[],"publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W1990362020","doi":"https://doi.org/10.2174/1568007024606258","mag":"1990362020","pmid":"https://pubmed.ncbi.nlm.nih.gov/12769627"},"language":"en","primary_location":{"id":"doi:10.2174/1568007024606258","doi":"https://doi.org/10.2174/1568007024606258","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568007024606258","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Target -CNS &amp; Neurological Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990362020"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041494494","display_name":"Mark John Millan","orcid":"https://orcid.org/0000-0002-6253-0301","observed_orcids":["https://orcid.org/0000-0002-6253-0301"]},"institutions":[{"id":"https://openalex.org/I4405268767","display_name":"Institut de Recherches Internationales Servier (France)","ror":"https://ror.org/01zej3n42","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405268767"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. Millan","raw_affiliation_strings":["Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France. mark.millan@fr.netgrs.com","Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France. mark.millan@fr.netgrs.com","institution_ids":["https://openalex.org/I4405268767"]},{"raw_affiliation_string":"Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041494494"],"corresponding_institution_ids":["https://openalex.org/I4405268767"],"apc_list":null,"apc_paid":null,"fwci":4.0728,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.93646346,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"1","issue":"2","first_page":"191","last_page":"213"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.03739999979734421,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8019999861717224},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8360000252723694},{"id":"https://openalex.org/keywords/glycine","display_name":"glycine","score":0.5580000281333923},{"id":"https://openalex.org/keywords/d-serine","display_name":"D-serine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/d-cycloserine","display_name":"D-cycloserine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8980000019073486},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7390000224113464},{"id":"https://openalex.org/keywords/glutamatergic-pathways","display_name":"glutamatergic pathways","score":0.7009999752044678},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.7200000286102295},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.5830000042915344},{"id":"https://openalex.org/keywords/cognitive-symptoms","display_name":"cognitive symptoms","score":0.6299999952316284},{"id":"https://openalex.org/keywords/nmda-receptor-subtypes","display_name":"NMDA receptor subtypes","score":0.75},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.7419056296348572},{"id":"https://openalex.org/C189184402","wikidata":"https://www.wikidata.org/wiki/Q3454536","display_name":"Kainate receptor","level":5,"score":0.6992518305778503},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.5850513577461243},{"id":"https://openalex.org/C115955781","wikidata":"https://www.wikidata.org/wiki/Q6063798","display_name":"Ionotropic effect","level":4,"score":0.5788185596466064},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5343922972679138},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5121617317199707},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.49991345405578613},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.4919013977050781},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4375613331794739},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.40486425161361694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34987109899520874},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.23925524950027466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1884533166885376}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018009","descriptor_name":"Receptors, Glycine","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018009","descriptor_name":"Receptors, Glycine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018009","descriptor_name":"Receptors, Glycine","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018684","descriptor_name":"Glycine Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1568007024606258","doi":"https://doi.org/10.2174/1568007024606258","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568007024606258","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Target -CNS &amp; Neurological Disorders","raw_type":"journal-article"},{"id":"pmid:12769627","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12769627","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets. CNS and neurological disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088790808","https://openalex.org/W2115303027","https://openalex.org/W2068262596","https://openalex.org/W1989781329","https://openalex.org/W1975780147","https://openalex.org/W2019960981","https://openalex.org/W1537092564","https://openalex.org/W118066032","https://openalex.org/W2095484800","https://openalex.org/W2035970676"],"abstract_inverted_index":{"Glutamatergic":[0],"pathways,":[1],"metabotropic":[2],"receptors,":[3,27],"and":[4,10,20,96,117,131,151,182,234,241],"ionotropic":[5],"alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionic":[6],"acid":[7],"(AMPA),":[8],"kainate":[9],"N-methyl-D-aspartate":[11],"(NMDA)":[12],"receptors":[13,55,233],"are":[14,70,80,101,136,187],"all":[15],"implicated":[16],"in":[17,39,51,103,112,165,204,219,238],"the":[18,66,75,120,139,158,166,220,227,239],"etiology":[19],"management":[21,221],"of":[22,98,108,122,157,168,177,195,209,212,217,222,230,243],"schizophrenia.":[23,223],"As":[24],"concerns":[25],"NMDA":[26,54,67,198,213],"open":[28],"channel":[29],"blockers":[30],"(OCBs)":[31],"such":[32,125],"as":[33,63,85,126],"phencyclidine":[34],"(PCP)":[35],"elicit":[36],"psychotic":[37,60,205,244],"symptoms":[38],"human":[40],"subjects.":[41],"This":[42,224],"observation":[43],"underpins":[44],"biochemical":[45],"studies":[46],"indicating":[47],"that":[48],"a":[49,91],"deficit":[50],"activity":[52],"at":[53,65,171],"may":[56,152,200,215],"be":[57,190,216],"associated":[58],"with":[59,154],"states.":[61,245],"Inasmuch":[62],"agonists":[64],"recognition":[68],"site":[69,79],"excitotoxic,":[71],"drugs":[72],"acting":[73],"via":[74],"co-agonist,":[76],"glycine(B)":[77],"(GLY(B))":[78],"more":[81],"promising":[82],"clinical":[83,114],"candidates":[84],"antipsychotic":[86,109],"agents.":[87],"Glycine":[88],"(GLY)":[89],"itself,":[90],"further":[92],"endogenous":[93,180,236],"agonist,":[94,141],"D-Serine,":[95],"inhibitors":[97],"GLY":[99,116,181],"reuptake":[100],"active":[102],"certain":[104,210],"experimental":[105],"models":[106],"predictive":[107],"properties.":[110],"Further,":[111,192],"controlled":[113],"trials,":[115],"D-Serine":[118,183],"enhance":[119],"ability":[121],"conventional":[123],"neuroleptics":[124],"haloperidol":[127],"to":[128,189],"improve":[129],"cognitive":[130],"negative":[132],"symptoms.":[133],"Their":[134],"actions":[135,156,170],"mimicked":[137],"by":[138,179],"partial":[140],"D-cycloserine":[142],"(DCS).":[143],"However,":[144],"these":[145],"agents":[146],"exert":[147],"little":[148],"effect":[149],"alone":[150],"interfere":[153],"therapeutic":[155],"atypical":[159],"antipsychotic,":[160],"clozapine.":[161],"An":[162],"important":[163],"issue":[164],"interpretation":[167],"drug":[169],"GLY(B)":[172,196,231],"sites":[173],"is":[174],"their":[175,235],"degree":[176],"occupation":[178],"-":[184],"although":[185],"they":[186],"unlikely":[188],"saturated.":[191],"distinct":[193],"\"subtypes\"":[194],"site-bearing":[197],"receptor":[199,214],"fulfill":[201],"differential":[202],"roles":[203],"states":[206],"Finally,":[207],"blockade":[208],"populations":[211],"use":[218],"article":[225],"reviews":[226],"complex":[228],"role":[229],"sites/NMDA":[232],"ligands":[237],"pathogenesis":[240],"treatment":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990362020","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
